Table 1.
Sources of exosomes or exosome-like nanovesicles modulating macrophages toward IBD repair
Exosomes/exosome-like nanovesicles source | Condition | Mechanism | Reference |
---|---|---|---|
Stem/stromal cell | |||
Hypoxia-prime adipose-derived stem cells | DSS-induced colitis | Control the HMGB1/TLR4/NF-κB signaling pathway to cause macrophage M2 polarization. | [97] |
Human umbilical cord MSCs | DSS-induced colitis | Prevent macrophage pyroptosis brought on by casp4 in an inflammatory setting. | [31] |
Human bone marrow-derived MSCs | DSS/TNBS induced colitis | Reduce inflammatory reactions, protects intestinal barrier integrity, polarizes M2b macrophages, and stimulates the production of IL-10. Primarily affects colonic macrophages. | [101] |
Human umbilical cord MSCs | DSS-induced colitis | Enhance the expression of the IL-10 gene and decreases the infiltration of macrophages, TNF-α, IL-1β, IL-6, iNOS, and IL-7 genes. | [96] |
Human umbilical cord MSCs | DSS-induced colitis | Suppress the release of IL-1β from mouse peritoneal macrophages and considerably lowers the relative expression of NLRP3, ASC, caspase-1, IL-18, and IL-1β in macrophages. | [29] |
LbL-MSCs | UC | Increase M2 macrophages to control inflammation while decreasing M1 macrophages. | [98] |
Human menstrual blood | DSS-induced colitis | Reduce colonic inflammation and polarize M2 macrophages in the colon. | [99] |
Bone marrow MSC | DSS-induced UC | Encourage the polarization of M2-like macrophages, which is indicated by a rise in the M2 marker CD163. Upregulate TGF-β and IL-10 and downregulate TNF-α, CCL-24, TNF-α, VEGF-A, and IFN-γ levels. | [100] |
Macrophage | |||
M2 | DSS-induced colitis | MiR-590-3p, highly concentrated in M2 exosomes, suppresses the production of proinflammatory cytokines such as IL-1β, IL-6, and tumor necrosis factor-α. | [49] |
M2 | DSS-induced colitis | Inhibit IL-1β, IL-6, and IL-17A. Offer protection against colitis produced by DSS, mostly through the CC chemokine 1 (CCL1)/CCR8 axis. | [11] |
Food | |||
Turmeric | Colitis | It increase the M1 phenotype’s transition to M2 macrophages and restores the impaired gut epithelial barrier. | [112] |
Ginseng | DSS-induced colitis | Stimulate the synthesis of anti-inflammatory macrophages while downregulating proinflammatory cytokines in proinflammatory macrophages. | [113] |
Spermidine | DSS-induced colitis | Increase the markers for M2 macrophages while decreasing the markers for M1 macrophages in the inflammatory colons. | [115] |
Colostrum | DSS-induced UC | Stimulate the growth of macrophages and colonic epithelial cells, reduce inflammation by efficiently eliminating ROS, and control the release of immune cytokines. | [50] |
Milk | DSS-induced UC | Reduce the inflammatory response by blocking the activation of the NLRP3 inflammasome and the TLR4-NF-κB signaling pathway. Stop the release of cytokines and macrophage polarization toward a proinflammatory phenotype. | [116] |
Other exosomes/EVs | |||
Trichinella spiralis | DSS-induced colitis | Activate M2 macrophages in the colon and prevent M1 macrophage polarization. | [117] |
HEK293T cells | Sepsis-induced intestinal damage | Minimize systemic inflammation and mortality while promoting M2 polarization by reducing mitochondrial reactive oxygen species (mtROS). | [118] |
Other immune cells | |||
G-MDSC | DSS-induced colitis | The G-MDSC exosome (containing Arg-1) inhibits the delayed-type hypersensitivity response, reduces the growth of CD4+ T cells, and decreases IFN-γ and TNF-α levels. | [110] |
Abbreviations: ASC, apoptosis-associated speck-like protein containing a caspase recruitment domain; DSS, dextran sulfate sodium; G, granulocytic; HMGB1, high mobility group box 1; IFN-γ, interferon-gamma; IL, interleukin; ILVs, intraluminal vesicles; iNOS, inducible nitric oxide synthase; M, macrophage; MDSC, myeloid-derived suppressor cells; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; NLRP3, NOD-like receptor family, pyrin domain-containing 3; ROS, reactive oxygen species; TGF-β, transforming growth factor beta; TLR4, Toll-like receptor 4; TNBS, 2,4,6-trinitrobenzenesulfonic acid solution; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor.